Yannick De Vlaeminck

4PUBLICATIONS
22CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Peripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 19, 2024
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties.

Heleen Hanssens, Fien Meeus, Emma L Gesquiere

|May 02, 2022
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model.

Thomas Ertveldt, Lien De Beck, Kirsten De Ridder

|Nov 02, 2021
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer.

Q Lecocq, P Debie, J Puttemans

|Dec 03, 2020
Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development.

Yannick De De Vlaeminck, Stefano Bonelli, Robin Maximilian Awad

Pageof 1

Frequent Collaborators

4 joint publications

Karine Breckpot

3 joint publications

Quentin Lecocq

3 joint publications

Nick Devoogdt

2 joint publications

Janik Puttemans